Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.
about
Rofecoxib for dysmenorrhoea: meta-analysis using individual patient dataReview article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humansShort-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trialCOX-2 inhibitors compared and contrasted.Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.Cyclooxygenase-2 inhibitors: promise or peril?Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind studyCyclooxygenase-2 inhibitors: do they have a role in emergency department prescribing?The impact of a novel herbal Shirazi Thymus Vulgaris on primary dysmenorrhea in comparison to the classical chemical Ibuprofen.Acupuncture as an Adjunct Treatment for Primary Dysmenorrhea: A Comparative Study.Comparison of the effect of fish oil and ibuprofen on treatment of severe pain in primary dysmenorrhea.Rofecoxib administration to paediatric patients undergoing adenotonsillectomy.Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: A network meta-analysis.A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea.Rofecoxib
P2860
Q24795236-3B8198F7-406F-40D2-BFCB-20A59AEC1278Q28174827-023A043B-DEB9-4E0E-8C19-621BF32324E2Q28469154-AB0E1123-F02E-4FD8-A8DF-3AB2C19A624EQ34515513-729656C0-31BD-4FA3-9080-214EEB2BBDC5Q34722610-8368A032-53D9-4D9A-8B09-8CB9AA29E28AQ35017693-CED9F118-3C2E-467B-A6FA-91D1D37551E1Q35595723-85F0B2B0-4530-4B04-857B-447F23DBED90Q35828904-C03DDCAE-426D-45D0-AF7D-4C1AF76521D0Q36938114-9C3275FC-65BE-4AB3-BCCD-9C96C51E662AQ37102204-C596C9F2-F09D-4EE5-BD39-088D8A9302DEQ37164145-C1B597A6-5A87-4382-B589-0068BAD20C25Q44939290-12B2303A-0DB3-4A6F-BC06-DF2E94A21959Q52627432-3DD44D58-4F2D-4722-B089-AFF02F4050A6Q55040597-E2669912-A1C4-4362-B926-9DA43E55B1E5Q56038570-FA97565F-FF02-485C-8A09-2D189EECA7A6
P2860
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@en
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@nl
type
label
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@en
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@nl
prefLabel
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@en
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@nl
P2093
P1476
Rofecoxib, a specific cyclooxy ...... a randomized controlled trial.
@en
P2093
P304
P356
10.1016/S0029-7844(99)00360-9
P407
P577
1999-10-01T00:00:00Z